Labflox

Lancet Lab. The leader in speciality laboratory testing services

Lancet Laboratories SA is one of the leading pathology laboratories operating throughout South Africa, providing vital diagnostic and monitoring pathology services in 9 provinces. Cerba Lancet Africa provides services to Botswana, Gabon, Ghana, Kenya, Mozambique, Rwanda, Nigeria, Eswatini, Tanzania, Uganda, Zimbabwe and Zambia.

Our Services

Digitally Transformed
Doctors App V2.0

Our Digital & Mobile Solutions

Lancet Laboratories has evolved over the years to stay on top of the latest trends and technology. The Lancet Laboratories Mobile Application and Pathportal version 3 assists doctors and patients to access their laboratory results from their mobile devices. The app is available on Google Playstore, Apple iStore and Huawei App Gallery.

Doctors and Patients App V1.7

Cerba Lancet Africa

Cerba-Lancet Africa is a joint-venture between Cerba Healthcare of France and Lancet Laboratories of South Africa.

Cerba Healthcare, a European leader in clinical pathology, operates mainly in France, Belgium, Luxembourg and Italy, through a network of over 500 laboratories and 50 technical facilities, servicing more than 50 countries in Europe, Africa and the Middle East. Cerba also specialises in clinical trial testing for the pharmaceutical and biotech industries through subsidiaries located across 5 continents.

The group offers diagnoses for in vitro testing, veterinary pathology and for the genetics market.

Cerba HealthCare has over 7000 employees, including 30 medical pathologists.

Lancet

ISO CERTIFIED

In our drive to maintain the high quality of our services, our laboratories are accredited by a number of accreditation authorities including SANAS. Our central support functions are certified to ISO 9001 with the aim of achieving customer satisfaction by meeting their expectations. 

Achieving Diagnostic Excellence

Expanding our operations through education, advanced skills development and job creation.

Labflox
Lancet
Labflox
Lancet Lab News

Stay up to date with our articles: